secwatch.observer — SEC 8-K summary
======================================

Issuer:     Damora Therapeutics, Inc. (DMRA)
CIK:        0001800315
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0000950170-24-105533
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Galecto completes 1-for-25 reverse stock split; post-split shares at 1,248,266
------------------------------------------------------------------------------

- Reverse stock split effective August 29, 2024; every 25 shares converted to 1 share.
- Computershare confirms total outstanding shares post-split: 1,248,266.
- Fractional shares resulting from the reverse split were rounded up to the nearest whole share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800315/000095017024105533/0000950170-24-105533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800315/000095017024105533/glto-20240910.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-105533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer